Polaris Group (6550.TW)

TWD 37.05

(-1.85%)

Revenue Summary of Polaris Group

  • Polaris Group's latest annual revenue in 2023 was 7.48 Million TWD , up 16.18% from previous year.
  • Polaris Group's latest quarterly revenue in 2024 Q2 was 32.06 Million TWD , up 15.51% from previous quarter.
  • Polaris Group reported a annual revenue of 6.43 Million TWD in annual revenue 2022, down -57.19% from previous year.
  • Polaris Group reported a annual revenue of 15.04 Million TWD in annual revenue 2021, up 59.84% from previous year.
  • Polaris Group reported a quarterly revenue of 32.06 Million TWD for 2024 Q2, up 15.51% from previous quarter.
  • Polaris Group reported a quarterly revenue of 4.89 Million TWD for 2023 Q4, up 506.31% from previous quarter.

Annual Revenue Chart of Polaris Group (2023 - 2016)

Created with Highcharts 11.1.0YearsRevenue201620172018201920202021202220230 TWD5000000 TWD10000000 TWD15000000 TWD20000000 TWD

Historical Annual Revenue of Polaris Group (2023 - 2016)

Year Revenue Revenue Growth
2023 7.48 Million TWD 16.18%
2022 6.43 Million TWD -57.19%
2021 15.04 Million TWD 59.84%
2020 9.41 Million TWD 0.0%
2019 - TWD 0.0%
2018 - TWD 0.0%
2017 - TWD 0.0%
2016 - TWD 0.0%

Peer Revenue Comparison of Polaris Group

Name Revenue Revenue Difference
Apex Biotechnology Corp. 1.67 Billion TWD 99.554%
Sinphar Pharmaceutical Co.,Ltd. 2.96 Billion TWD 99.748%
Panion & Bf Biotech Inc. 1.88 Billion TWD 99.602%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 2.08 Billion TWD 99.641%
GenMont Biotech Incorporation 318.01 Million TWD 97.648%
Abnova (Taiwan) Corporation 382.05 Million TWD 98.042%
Adimmune Corporation 1.78 Billion TWD 99.581%
Tanvex BioPharma, Inc. 61.41 Million TWD 87.818%
Energenesis Biomedical CO.,LTD. 7.15 Million TWD -4.512%
UnicoCell Biomed Co., Ltd. 24.58 Million TWD 69.576%
PELL Bio-Med Technology Co. Ltd. 18.03 Million TWD 58.515%